Indaptus Therapeutics Stock Price on November 27, 2024
| INDP Stock | USD 1.02 0.01 0.97% |
Below is the normalized historical share price chart for Indaptus Therapeutics extending back to December 26, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Indaptus Therapeutics stands at 1.02, as last reported on the 29th of November, with the highest price reaching 1.04 and the lowest price hitting 1.02 during the day.
If you're considering investing in Indaptus Stock, it is important to understand the factors that can impact its price. Indaptus Therapeutics holds Efficiency (Sharpe) Ratio of -0.0535, which attests that the entity had a -0.0535% return per unit of risk over the last 3 months. Indaptus Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Indaptus Therapeutics' Market Risk Adjusted Performance of (0.16), risk adjusted performance of (0.04), and Standard Deviation of 7.4 to validate the risk estimate we provide.
At this time, Indaptus Therapeutics' Total Stockholder Equity is relatively stable compared to the past year. As of 11/29/2024, Liabilities And Stockholders Equity is likely to grow to about 23.5 M, while Capital Stock is likely to drop slightly above 76.6 K. . At this time, Indaptus Therapeutics' Price Book Value Ratio is relatively stable compared to the past year. As of 11/29/2024, Price To Book Ratio is likely to grow to 1.29, while Price To Operating Cash Flows Ratio is likely to drop (1.16). Indaptus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 4th of August 2015 | 200 Day MA 1.8845 | 50 Day MA 1.2384 | Beta 1.131 |
Indaptus |
Sharpe Ratio = -0.0535
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | INDP |
Estimated Market Risk
| 7.52 actual daily | 66 66% of assets are less volatile |
Expected Return
| -0.4 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Indaptus Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Indaptus Therapeutics by adding Indaptus Therapeutics to a well-diversified portfolio.
Price Book 1.7495 | Book Value 1.437 | Enterprise Value 3.2 M | Enterprise Value Ebitda 1.0264 | Shares Float 7.5 M |
Related Headline
Pasithea Therapeutics Headline on 27th of November 2024
Pasithea Therapeutics Corporation Enters into At The Market ... by thelincolnianonline.com
On November 26, 2024, Pasithea Therapeutics Corp., a Delaware-based biopharmaceutical company, announced that it has entered into an At The Market Offering Agreement with H.C. Wainwright Co., LLC, acting as the Sales Agent. The agreement enables Pasithea Therapeutics to offer for sale its common stock, with a par value of 0.0001 per
Indaptus Therapeutics Valuation on November 27, 2024
It is possible to determine the worth of Indaptus Therapeutics on a given historical date. On November 27, 2024 Indaptus was worth 1.04 at the beginning of the trading date compared to the closed value of 1.03. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Indaptus Therapeutics stock. Still, in general, we apply an absolute valuation method to find Indaptus Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Indaptus Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Indaptus Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 1.06 | 1.06 | 1.01 | 1.04 | 8,051 | |
11/27/2024 | 1.04 | 1.06 | 1.01 | 1.03 | 45,789 |
| 1.04 | 1.06 | 1.01 | 1.03 | 0.00 |
| Backtest Indaptus Therapeutics | | | Indaptus Therapeutics History | | | Indaptus Therapeutics Valuation | Previous | Next |
Indaptus Therapeutics Trading Date Momentum on November 27, 2024
| On November 29 2024 Indaptus Therapeutics was traded for 1.03 at the closing time. The top price for the day was 1.06 and the lowest listed price was 1.01 . There was no trading activity during the period 0.0. Lack of trading volume on November 29, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.97% . |
Indaptus Therapeutics Fundamentals Correlations and Trends
By evaluating Indaptus Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Indaptus Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Indaptus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Indaptus Therapeutics Stock history
Indaptus Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Indaptus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Indaptus Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Indaptus Therapeutics stock prices may prove useful in developing a viable investing in Indaptus Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 8.4 M | 4.8 M | |
| Net Loss | -12.9 M | -12.2 M |
Indaptus Therapeutics Stock Technical Analysis
Indaptus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Indaptus Therapeutics Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Indaptus Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Indaptus Therapeutics November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Indaptus Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Indaptus Therapeutics shares will generate the highest return on investment. By undertsting and applying Indaptus Therapeutics stock market strength indicators, traders can identify Indaptus Therapeutics entry and exit signals to maximize returns
Indaptus Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Indaptus Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Indaptus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Indaptus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.77) | |||
| Total Risk Alpha | (1.57) | |||
| Treynor Ratio | (0.17) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Indaptus Stock Analysis
When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.